Unlocking Cardiovascular Benefits: Which Patients Profit Most from SGLT2 and GLP-1 Diabetes Medications?
2025-02-06Medical News Today
Recent research sheds light on the effectiveness of newer type 2 diabetes medications, specifically SGLT2 and GLP-1 inhibitors, in reducing the risk of cardiovascular disease. These medications have shown promise in improving cardiovascular health, p ...Read more
